Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
QUEBEC CITY, Aug. 8, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today reported financial and operating results as at and for the second quarter ended June 30, 2013.
Hey, check out all the engineering jobs. Post your resume today!
